Assessing the distribution of parameters in models of ligand-receptor interaction: To log or not to log

Trends in Pharmacological Sciences

Volumn 19, Issue 9, 1998, Pages 351-357

  Christopoulos, Arthur ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; LIGAND BINDING; MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; SIMULATION; STATISTICAL ANALYSIS;

LIGANDS; MODELS, STATISTICAL; MONTE CARLO METHOD; RECEPTORS, DRUG; STATISTICS;

EID: 0032436491     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01240-1     Document Type: Article

References (28)

1. Wells, J. W. (1992) in Receptor-Ligand Interactions: A Practical Approach (Hulme, E. C., ed.), pp. 289-395, Oxford University Press.
2. Motulsky, H. J. (1995) Intuitive Biostatistics, Oxford University Press.
3. Fleming W. W., Westfall D. P., De La Lande I. S., Jellet L. B. J. Pharmacol. Exp. Ther. 181:1972;339-345.
4. DeLean A.et al. Mol. Pharmacol. 21:1982;5-16.
5. Hancock A. A.et al. Trends Pharmacol. Sci. 9:1988;29-32.
6. Jenkinson, D. H. (1996) in Textbook of Receptor Pharmacology (Foreman, J. C. and Johansen, T., eds), pp. 4-62, CRC Press.
7. Kenakin, T. (1997) Molecular Pharmacology: A Short Course, Blackwell Science.
8. Bowen W. P., Jerman J. C. Trends Pharmacol. Sci. 16:1995;413-417.
9. GraphPad PRISM 2.01 Manual (1995) GraphPad Software Inc.
10. Press, W. H., Teukolsky, S. A., Vetterling, W. T. and Flannery, B. P. (1992) Numerical Recipes in C (2nd edn), Cambridge University Press.
11. De Lean A.et al. J. Biol. Chem. 255:1980;7108-7117.
12. Ehlert F. J. Mol. Pharmacol. 33:1988;187-194.
13. Lazareno S., Birdsall N. J. M. Mol. Pharmacol. 48:1995;362-378.
14. Costa T.et al. Mol. Pharmacol. 41:1992;549-560.
15. Onaran H. O.et al. Mol. Pharmacol. 43:1993;245-256.
16. Kenakin, T. P. (1997) Pharmacologic Analysis of Drug-Receptor Interaction (3rd edn), Lippincott-Raven Press.
17. Lee N. H., El-Fakahany E. E. Biochem. Pharmacol. 42:1991;199-205.
18. Tuček S., Proška J. Trends Pharmacol. Sci. 16:1995;205-212.
19. Christopoulos A., Lanzafame A., Mitchelson F. Clin. Exp. Pharmacol. Physiol. 25:1998;184-194.
20. Spalding T. A.et al. Biochemistry. 36:1997;10109-10116.
21. Wregget K. A., Wells J. W. J. Biol. Chem. 270:1995;22488-22499.
22. Black J. W., Leff P. Proc. R. Soc. London Ser. B. 220:1983;141-162.
23. Leff P. Trends Pharmacol. Sci. 9:1988;395-398.
24. Leff P.et al. J. Pharmacol. Methods. 23:1990;225-237.
25. Bürgisser E. J. Recept. Res. 3:1983;261-281.
26. Karlsson M. O., Neil A. Mol. Pharmacol. 35:1989;59-66.
27. Motulsky H. J., Ransnas L. A. FASEB J. 1:1987;365-374.
28. Lew M. J., Angus J. A. Trends Pharmacol. Sci. 16:1995;328-337.